These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 11205265

  • 1. Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C.
    Yang Q, Sakurai T, Yoshimura G, Takashi Y, Suzuma T, Tamaki T, Umemura T, Nakamura Y, Nakamura M, Utsunomiya H, Mori I, Kakudo K.
    Anticancer Res; 2000; 20(6B):4319-22. PubMed ID: 11205265
    [Abstract] [Full Text] [Related]

  • 2. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y.
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [Abstract] [Full Text] [Related]

  • 3. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A, International Breast Cancer Study Group.
    Cancer; 2003 Apr 01; 97(7):1591-600. PubMed ID: 12655514
    [Abstract] [Full Text] [Related]

  • 4. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay.
    Furukawa T, Kubota T, Tanino H, Oura S, Yuasa S, Murate H, Morita K, Kozakai K, Yano T, Hoffman RM.
    Anticancer Res; 2000 Apr 01; 20(5C):3657-8. PubMed ID: 11268434
    [Abstract] [Full Text] [Related]

  • 5. Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer.
    Staalesen V, Leirvaag B, Lillehaug JR, Lønning PE.
    Clin Cancer Res; 2004 May 15; 10(10):3438-43. PubMed ID: 15161699
    [Abstract] [Full Text] [Related]

  • 6. Pirarubicin might partly circumvent the P-glycoprotein-mediated drug resistance of human breast cancer tissues.
    Kubota T, Furukawa T, Tanino H, Oura S, Murata H, Yuasa S, Morita K, Ueno J, Kozakai R, Yano T.
    Anticancer Res; 1998 May 15; 18(2A):967-72. PubMed ID: 9615748
    [Abstract] [Full Text] [Related]

  • 7. Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer.
    Hosaka N, Ichikawa Y, Ishikawa T, Nagashima Y, Kunisaki C, Takahashi M, Moriwaki Y, Akiyama H, Yamaguchi S, Ota M, Ooki S, Ike H, Shimada H.
    Anticancer Res; 2001 May 15; 21(1A):229-35. PubMed ID: 11299739
    [Abstract] [Full Text] [Related]

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 9. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T, Kuraishi Y, Aiba K, Inoue K.
    Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1566-72. PubMed ID: 3927846
    [Abstract] [Full Text] [Related]

  • 10. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH.
    Cancer J Sci Am; 1998 Jun 01; 4(1):41-5. PubMed ID: 9467045
    [Abstract] [Full Text] [Related]

  • 12. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
    Geng M, Yin YC, Cao YC, Fu ZJ, Wang XY, Tai YH.
    Zhonghua Zhong Liu Za Zhi; 2007 Nov 01; 29(11):838-41. PubMed ID: 18396642
    [Abstract] [Full Text] [Related]

  • 13. E-cadherin-dependent intercellular adhesion enhances chemoresistance.
    Nakamura T, Kato Y, Fuji H, Horiuchi T, Chiba Y, Tanaka K.
    Int J Mol Med; 2003 Nov 01; 12(5):693-700. PubMed ID: 14532995
    [Abstract] [Full Text] [Related]

  • 14. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
    Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P.
    Cancer Res; 2006 Apr 15; 66(8):4263-72. PubMed ID: 16618750
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC, Chan JK, Lee KC, Hsiao WL.
    J Pathol; 2001 May 15; 194(1):35-42. PubMed ID: 11329139
    [Abstract] [Full Text] [Related]

  • 16. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H.
    Anticancer Res; 2000 May 15; 20(2B):1237-44. PubMed ID: 10810427
    [Abstract] [Full Text] [Related]

  • 17. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.
    Clin Cancer Res; 2003 Nov 15; 9(15):5652-9. PubMed ID: 14654548
    [Abstract] [Full Text] [Related]

  • 18. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
    Schneider J, Lucas R, Sánchez J, Ruibal A, Tejerina A, Martín M.
    Anticancer Res; 2000 Nov 15; 20(6B):4373-7. PubMed ID: 11205274
    [Abstract] [Full Text] [Related]

  • 19. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R, Gariboldi MB, Molteni R, Monti E.
    Oncol Rep; 2008 Sep 15; 20(3):625-30. PubMed ID: 18695915
    [Abstract] [Full Text] [Related]

  • 20. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
    Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY.
    J Surg Oncol; 2003 Aug 15; 83(4):241-7. PubMed ID: 12884237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.